Quick Answer

Yes — both partners need treatment simultaneously, or reinfection becomes near-certain. Most states support expedited partner therapy (EPT): clinicians prescribe medication for partners without examining them, breaking reinfection cycles efficiently.

  • Reinfection rates without partner treatment run 15–30% within months.
  • EPT is legal in most U.S. states for chlamydia and gonorrhea specifically.
  • Health-department disease intervention specialists notify partners for reportable conditions free.
  • Partners may harbor identical infections asymptomatically — 'they feel fine' proves nothing.

The Landscape

Ping-pong dynamics make solo treatment futile: you cure, they reinfect, repeat. Simultaneous treatment collapses the cycle mathematically — which is why EPT exists as public-health policy rather than being left to awkward negotiation.

Delivering the news

Script beats improvisation: 'I tested positive for [X]; the CDC says you need testing/treatment too — here's what worked for me.' Text acceptable; anonymous notification services exist for harder conversations.

Different-infection scenarios

Partners of syphilis/HIV diagnoses need clinical evaluation beyond EPT scope — staged workups, PEP consideration for HIV exposure, serologic staging for syphilis contacts.

Treatment Windows by Infection

Bacterial infections clear with antibiotics measured in days: single-dose azithromycin or a ceftriaxone shot for gonorrhea, seven days of doxycycline for chlamydia, penicillin injections for syphilis staged by duration. Viral infections play a longer game — suppressive antivirals for herpes, daily ART driving HIV to undetectable, and 8–12-week antiviral courses curing over 95% of hepatitis C cases.

⚕️ This page is educational and does not replace advice from a licensed clinician. If you may have been exposed to an STI, get tested — most infections are manageable, and many are fully curable.

Sources & Further Reading

Figures reflect CDC surveillance and WHO estimates; they are population statistics, not personal risk predictions.